OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Inhibition of FLT3-ITD Kinase in Acute Myeloid Leukemia by New Imidazo[1,2-b]pyridazine Derivatives Identified by Scaffold Hopping
Petra Břehová, Eva Řezníčková, Kryštof Škach, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 16, pp. 11133-11157
Open Access | Times Cited: 6
Petra Břehová, Eva Řezníčková, Kryštof Škach, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 16, pp. 11133-11157
Open Access | Times Cited: 6
Showing 6 citing articles:
Pyridazine: A privileged scaffold in the development of 21st-century pesticides
Chao Chen, Geng Wang, Ke Li, et al.
Chinese Chemical Letters (2025), pp. 110902-110902
Closed Access
Chao Chen, Geng Wang, Ke Li, et al.
Chinese Chemical Letters (2025), pp. 110902-110902
Closed Access
Discovery of FLT3-targeting PROTACs with potent antiproliferative activity against acute myeloid leukemia cells harboring FLT3 mutations
Zhijie Wang, Xun Lu, Canlin Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116237-116237
Closed Access | Times Cited: 2
Zhijie Wang, Xun Lu, Canlin Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116237-116237
Closed Access | Times Cited: 2
Structure-Based Optimization of Pyrazinamide-Containing Macrocyclic Derivatives as Fms-like Tyrosine Kinase 3 (FLT3) Inhibitors to Overcome Clinical Mutations
Xuan Zheng, Zhiwen Chen, Ming Guo, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 5, pp. 1485-1506
Closed Access | Times Cited: 2
Xuan Zheng, Zhiwen Chen, Ming Guo, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 5, pp. 1485-1506
Closed Access | Times Cited: 2
Recent contributions of pyridazine as a privileged scaffold of anticancer agents in medicinal chemistry: An updated review
Ziqiang Liu, Qian Zhang, Yulin Liu, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 111, pp. 117847-117847
Closed Access | Times Cited: 1
Ziqiang Liu, Qian Zhang, Yulin Liu, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 111, pp. 117847-117847
Closed Access | Times Cited: 1
Targeting cancer using scaffold-hopping approaches: illuminating SAR to improve drug design
Shivani, Towhidur Rahaman, Sandeep Chaudhary
Drug Discovery Today (2024) Vol. 29, Iss. 9, pp. 104115-104115
Closed Access
Shivani, Towhidur Rahaman, Sandeep Chaudhary
Drug Discovery Today (2024) Vol. 29, Iss. 9, pp. 104115-104115
Closed Access
Identification of furo[2,3-d]pyrimidin-4-ylsulfanyl-1,3,4-thiadiazole derivatives as novel FLT3-ITD inhibitors
Mahfam Moradi, Ali Mousavi, Eva Řezníčková, et al.
European Journal of Medicinal Chemistry (2024) Vol. 280, pp. 116962-116962
Closed Access
Mahfam Moradi, Ali Mousavi, Eva Řezníčková, et al.
European Journal of Medicinal Chemistry (2024) Vol. 280, pp. 116962-116962
Closed Access
